Monsenso announces new chairman of the Board

Monsenso announces new chairman of the Board

by | Apr 14, 2021 | News

Copenhagen, (April 14, 2021): Monsenso, a leading provider of digital mental health solutions, today announced the appointment of Maria Hjorth as Chairman of the Board, as replacement of Jukka Pekka Pertola, who had decided to resign to reduce his number of board seats. 

The company’s Annual General Meeting was held today, in which Maria Hjorth was elected to join the board. Immediately after the Annual General Meeting, the Board of Directors held its constituent meeting and elected Maria Hjorth as Chairman and re-elected Jakob Eyvind Bardram as Deputy Chairman.

The appointment of Maria Hjorth as chairman follows changes in January where Peter Høngaard Andensen and Jacob Hahn Michelsen were elected to the Board with the aim to further strengthen the competences and the diversity of the board.

 “Maria brings extensive experience and accomplishments from the financial sector, lately from a position as CEO at VP Securities A/S, in addition to her board experience from Trifork, May Invest Holding A/S and Asetek” says CEO Thomas Lethenborg. “Her experiences from top management, financial businesses, investor relations and M&A is a great supplement to the rest of the board”. 

The Board and the management of Monsenso would like to thank Jukka Pertola for his great efforts in supporting the management, the company in general and particularly the listing on Nasdaq First North Growth Market in 2020.

“It has been a great pleasure to have served as Chairman of the Monsenso Board of Directors,” said Jukka Pertola. “I am very proud of our accomplishments over the past years, and I am confident that with Maria’s leadership, and the changes made in January, Monsenso will continue to grow and expand it’s positive impact in driving better mental health for more people at lower cost.”

The Board of Directors now consists of Maria Hjorth (Chairman), Jakob E. Bardram (Deputy Chairman), Jeppe Ø. Øvlesen, Peter Høngaard Andersen and Jacob Hahn Michelsen. 

To read the Danish version, click here.

For additional information contact:

Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

The EcoWeb project has recruited more than 1600 participants across four countries despite COVID-19

The EcoWeb project has recruited more than 1600 participants across four countries despite COVID-19

by | Mar 4, 2021 | News

Since the EcoWeB project launched MyMoodCoach (an app powered by Monsenso) in November 2020 it has recruited more than 1600 young participants in Belgium, UK, Spain and Germany.

The EcoWeB research study, led by Professor Ed Watkins University of Exeter, seeks to understand what influences mood, how emotions change over time, and which emotional skills increase well-being among youth.

The participants are asked to use MyMoodCoach to monitor their emotions in daily life, while giving them access to “Tools” and “Challenges” to boost their mental health and wellbeing. ‘Tools’ provide the participants with strategies to help them if they feel sad, stressed, anxious or have a problem. ‘Challenges’ help them to learn new skills, develop a positive mindset, improve their confidence and gain insight into their emotions.

The strong pick up of MyMoodCoach reflects a desire among youth to take better care of their mental wellbeing.

“We are very pleased to contribute to this project, as young people have been particularly impacted by COVID-19.” says Thomas Lethenborg, CEO of Monsenso. “Mobile health solutions have proved true value during the pandemic, allowing both clinical practice and important research projects to continue despite lockdowns.”

About the project:

The EcoWeB project is led by Professor Ed Watkins, University of Exeter, and involves 13 different institutions across 8 European nations (the UK, Germany, Belgium, Spain, Greece, the Czech Republic, Denmark, and Switzerland). The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 754657.

About Monsenso digital health solution:
Monsenso is an innovative technology company offering a digital health solution used for decentralised trials, remote patient monitoring and treatment support. Our mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data. Our solution helps optimise the treatment and gives a detailed overview of an individual’s health through the collection of outcome, adherence, and behavioural data. It connects individuals, carers, and health care providers to enable personalised treatment, remote care, and early intervention. We collaborate with health and social care, pharmaceuticals, and leading researcher worldwide in our endeavours to deliver solutions that fit into the life of patients and health care professionals. To learn more visit  www.monsenso.com.

BOOK A DEMO